MICHELLE ANGUS: Open Payments
NPI 1336651504 · LYNCHBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$394 in 5 payments from 4 companies in 2025. Trend: 2023 $396 · 2024 $578 · 2025 $394
Food & beverage: $394
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $243 |
| E.R. Squibb & Sons, L.L.C. | 1 | $121 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
| Alkermes, Inc. | 1 | $14 |
Products named: INGREZZA, COBENFY, INVEGA SUSTENNA, ARISTADA.
Industry payments across VA — which companies pay providers there.
